Sort   by:  
 Page size 
Genomicsena-DATASET-CGNT-13-01-2017-11:31:00:793-49 - samples
Total stranded TruSeq RNA sequencing by Illumina of six tumor samples from six cases of pediatric Pilocytic astrocytoma. The data is published in the following paper: Tomic TT, Olausson J, Wilzen A, Sabel M, Truve K, Sjogren H, Dosa S, Tisell M, Lannering B, Enlund F, Martinsson T, Aman P, Abel F. A...
EGAD00001003143 | EGA
TranscriptomicsTranscription profiling of human patients with unfavourable vs favourable neuroblastoma
Tumors were divided into two biologically based groups by the following criteriaï¾’s: Favorable (F); NB patient with no evidence of disease (NED) with a primary tumor staged 1-3 with no MYCN-amplification, no 1pdel, and no 11qdel. Unfavorable (UF); NB patient with advanced stage of disease or dead o...
ORGANISM(S): Homo sapiens 
2009-09-05 | E-MEXP-2250 | biostudies-arrayexpress
GenomicsClinical Genetics Pediatric Brain Tumor (CGPBT)-group at Gothenburg University.
Data Access Committee EGAC00001000572
EGAC00001000572 | EGA
Genomicsena-DATASET-CGNT-05-12-2015-13:59:52:975-75 - samples
Exome sequencing of nine PCC/PGL tumors, SF and FFPE samples
EGAD00001001854 | EGA
GenomicsMalignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion genes
One out of ten patients with pheochromocytoma (PCC) and paraganglioma (PGL) develop malignant disease. Today there are no reliable pathological methods to predict malignancy at the time of diagnosis. Tumors harboring mutations in the succinate dehydrogenase subunit B (SDHB) gene often metastasize bu...
EGAS00001001601 | EGA
GenomicsDATA ACCESS AGREEMENT CGNT- GROUP COMMITTEE for project "Exome sequencing of 22 Pheochromocytoma/paraganglioma tumors" at Gothenburg University.
Data Access Committee EGAC00001000411
EGAC00001000411 | EGA
GenomicsRNA-sequencing of six Pilocytic astrocytoma tumors
Pilocytic astrocytoma (PA) is the most common pediatric brain tumor. A recurrent feature of PA is deregulation of the mitogen activated protein kinase (MAPK) pathway most often through KIAA1549-BRAF fusion, but also by other BRAF- or RAF1-gene fusions and point mutations (e.g. BRAFV600E). These feat...
EGAS00001002149 | EGA
Sort   by:  
 Page size